ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study to Evaluate rhuMab 2C4 and Gemcitabine in Subjects With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

ClinicalTrials.gov ID: NCT00096993

Public ClinicalTrials.gov record NCT00096993. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 17, 2026, 5:55 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Efficacy of Pertuzumab (rhuMAb 2C4) in Combination With Gemcitabine and the Effect of Tumor-Based HER2 Activation in Subjects With Platinum-Resistant Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Study identification

NCT ID
NCT00096993
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Genentech, Inc.
Industry
Enrollment
131 participants

Conditions and interventions

Interventions

  • Gemcitabine Drug
  • Pertuzumab Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 2004
Primary completion
Aug 31, 2007
Completion
Aug 31, 2007
Last update posted
Jun 9, 2015

2005 – 2007

United States locations

U.S. sites
41
U.S. states
21
U.S. cities
35
Facility City State ZIP Site status
Univ. of Alabama at Birmingham Birmingham Alabama 35233
Comprehensive Cancer Institute Huntsville Alabama 35801
Northwest Alabama Cancer Center Muscle Shoals Alabama 35661
Arizona Cancer Center Tucson Arizona 85724
Alta Bates Comp. Cancer Ctr Berkeley California 94704
California Cancer Crae, Inc Greenbrae California 94904
Cedars-Sinai Medical Center Los Angeles California 90048
University of California, Los Angeles Los Angeles California 90095
Ventura County Hematology Oncology Specialists Oxnard California 93030
Sutter Cancer Center Sacramento California 95816
Southern California Permanente Medical Group (Kaiser) San Diego California 92120
Sharp Healthcare San Diego California 92123
Norwalk Medical Group Norwalk Connecticut 06856
Hematology Oncology, P.C. Stamford Connecticut 06902
Integrated Community Oncology Network Jacksonville Florida 32256
Florida Hospital Orlando Florida 32804
Memorial Health Univ. Med. Ctr. Savannah Georgia 31404
St. Luke's Mountain States Tumor Institute Boise Idaho 83712
North Idaho Cancer Center Coeur d'Alene Idaho 83814
University Of Chicago Chicago Illinois 60637
Carle Clinic Association Urbana Illinois 61801
Indiana University Indianapolis Indiana 46202
St. Vincent Hospital Indianapolis Indiana 46260
Cancer Center of Kansas Wichita Kansas 67214
University of Kentucky Lexington Kentucky 40536
Greater Baltimore Medical Center Baltimore Maryland 21204
Franklin Square Hospital Center Baltimore Maryland 21237
Massachusetts General Hospital Boston Massachusetts 02114
Dana-Farber Cancer Institute Boston Massachusetts 02115
Wayne State Univ. Barbara Ann Karmanos Cancer Inst. Detroit Michigan 48201
Center for Cancer and Hematologic Disease Cherry Hill New Jersey 08003
Cooper Health System Voorhees Township New Jersey 08043
Carolinas Medical Center Charlotte North Carolina 28203
Ohio State University College of Medicaine Columbus Ohio 43210
Pelvic Surgery Assoc. Columbus Ohio 43222
Oklahoma Univ. Medical Center Oklahoma City Oklahoma 73104
Corvallis Clinic Corvallis Oregon 97330
Kaiser Permanente Northwest Division Portland Oregon 97227
Womens and Infants Hospital Providence Rhode Island 02905
Northern Virginia Pelvic Surgery Assoc. Annandale Virginia 22003
Carilion Gyn/Onc Roanoke Virginia 24014

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00096993, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 9, 2015 · Synced May 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00096993 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →